GENEVA, June 2 -- OXFORD DRUG DESIGN LIMITED (Oxford Centre For InnovationNew RoadOxford OX1 1BY) filed a patent application (PCT/EP2024/082960) for "2-AMINO-N-(OXO-ARYL-LAMBDA6-SULFANYLIDENE)ACETAMIDE COMPOUNDS AND THEIR THERAPEUTIC USE" on Nov 20, 2024. With publication no. WO/2025/108986, the details related to the patent application was published on May 30, 2025.

Notably, the patent application was submitted under the International Patent Classification (IPC) system, which is managed by the World Intellectual Property Organization (WIPO).

Inventor(s): EDMUND, Grace (c/o OXFORD DRUG DESIGN LIMITEDOxford Centre For InnovationNew RoadOxford OX1 1BY), FINN, Paul W. (c/o OXFORD DRUG DESIGN LIMITEDOxford Centre For InnovationNew RoadOxford ...